TMCI — TREACE MEDICAL CONCEPTS, INC.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1630627 ·
Last close
$4.50
Market Cap
$292.66M
52W High
$7.08
52W Low
$1.17
ADV30
255,433
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 45,376,000 | 35,607,000 | -14,958,000 | -15,873,000 | 181,055,000 | 12,610,000 | 113,318,000 |
| Mar 2026 | 47,198,000 | 37,407,000 | -17,167,000 | -17,961,000 | 184,102,000 | 9,544,000 | 106,911,000 |
| Dec 2025 | 62,519,000 | 50,401,000 | -5,922,000 | -9,394,000 | 190,581,000 | 10,708,000 | 103,249,000 |
| Sep 2025 | 50,214,000 | 39,706,000 | -15,676,000 | -16,288,000 | 196,591,000 | 7,686,000 | 107,404,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-12,928,000
Investing CF
$7,329,000
Financing CF
$1,771,000
CapEx
$-13,036,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.97
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-266,953,000
Inventory
$36,366,000
Receivables
$30,358,000
ST Investments
$42,310,000
EBIT TTM
$-55,462,000
Pretax Income TTM
$-61,041,000
Interest Exp TTM
$5,579,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$205,307,008
EBITDA
$-46,350,000
Free Cash Flow
$-6,252,375
Enterprise Value
$320,736,832
Total Cash
$45,619,000
Total Debt
$73,050,000
Shares Out
65,034,552
Trailing EPS
$-0.92
Book Value
$1.04
ROE
-72.0%
ROA
-17.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 212,690,000 | -54,154,000 | -59,002,000 | 190,581,000 | 103,249,000 | 87,332,000 | -15,970,000 |
| Dec 2024 | 209,357,000 | -55,688,000 | -55,743,000 | 217,094,000 | 104,202,000 | 112,892,000 | -37,167,000 |
| Dec 2023 | 187,118,000 | -51,428,000 | -49,527,000 | 251,907,000 | 113,969,000 | 137,938,000 | -34,575,000 |
| Dec 2022 | 141,838,000 | -34,844,000 | -42,815,000 | 159,024,000 | 98,495,000 | 60,529,000 | -30,648,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.85
Max Pain — expiry 2027-03-19
max pain strike: $5.00 · spot: $4.48 · call oi: 55 · put oi: 1,567
Expected Move to 2027-03-19:
±$2.33
(51.90%) —
implied range
$2.16 –
$6.81
· ATM straddle on $5.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MOBI | Mobia Medical, Inc. | $301.62M | $9.06 | — |
| AVHHL | AVITA Medical, Inc. | $309.27M | $2.00 | — |
| ANIK | Anika Therapeutics, Inc. | $272.61M | $20.37 | — |
| OSUR | ORASURE TECHNOLOGIES INC | $271.05M | $3.93 | — |
| TLSI | TriSalus Life Sciences, Inc. | $267.23M | $4.34 | — |
News headlines (Yahoo Finance, 1h cache)
Treace Medical (TMCI) Reports Five-Year Bunion Results. Can Evidence Drive Adoption?
2026-09-23 00:38 · Yahoo
Treace Highlights Product Innovations and Clinical Data Across its Expanding Foot & Ankle Portfolio at the 2026 AOFAS Annual Meeting
2026-09-15 21:06 · Yahoo
Treace Medical (TMCI) Q2 2026 Earnings Call Transcript
2026-08-14 13:58 · Yahoo
Treace Medical Concepts Inc (TMCI) (Q2 2026) Earnings Call Highlights: Revenue Declines 4% but ...
2026-08-07 19:00 · Yahoo
Treace Medical Concepts Q2 Earnings Call Highlights
2026-08-07 18:04 · Yahoo
Treace Medical Concepts (TMCI) Reports Q2 Loss, Tops Revenue Estimates
2026-08-07 12:20 · Yahoo
Treace Medical Concepts Reports Second Quarter 2026 Financial Results
2026-08-07 11:05 · Yahoo
Treace to Report Second Quarter 2026 Financial Results on August 7, 2026
2026-07-24 11:05 · Yahoo
Treace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System
2026-06-18 11:05 · Yahoo
Treace Medical Concepts, Inc. Q2 2026 Earnings Call Summary
2026-08-07 21:12 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.